These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 25538279)

  • 41. Topical Mineralocorticoid Receptor Blockade Limits Glucocorticoid-Induced Epidermal Atrophy in Human Skin.
    Maubec E; Laouénan C; Deschamps L; Nguyen VT; Scheer-Senyarich I; Wackenheim-Jacobs AC; Steff M; Duhamel S; Tubiana S; Brahimi N; Leclerc-Mercier S; Crickx B; Perret C; Aractingi S; Escoubet B; Duval X; Arnaud P; Jaisser F; Mentré F; Farman N
    J Invest Dermatol; 2015 Jul; 135(7):1781-1789. PubMed ID: 25668238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist.
    Kawata T; Daimon M; Hasegawa R; Teramoto K; Toyoda T; Sekine T; Yamamoto K; Uchida D; Himi T; Yoshida K; Komuro I
    Am Heart J; 2006 Apr; 151(4):798.e9-15. PubMed ID: 16569537
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Pharmacological approaches to coronary microvascular dysfunction.
    Guarini G; Huqi A; Morrone D; Capozza P; Todiere G; Marzilli M
    Pharmacol Ther; 2014 Dec; 144(3):283-302. PubMed ID: 25004087
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The acute effects of different spironolactone doses on cardiac function in streptozotocin-induced diabetic rats.
    Vranic A; Simovic S; Ristic P; Nikolic T; Stojic I; Srejovic I; Zivkovic V; Jakovljevic V; Djuric D
    Can J Physiol Pharmacol; 2017 Nov; 95(11):1343-1350. PubMed ID: 28746811
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Bullous pemphigoid induced by spironolactone].
    Modeste AB; Cordel N; Courville P; Gilbert D; Lauret P; Joly P
    Ann Dermatol Venereol; 2002 Jan; 129(1 Pt 1):56-8. PubMed ID: 11937932
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Mineralocorticoid receptor inhibitor for long-standing central serous chorioretinopathy.
    Suzuki A; Takano Y; Ando Y; Ogawa J; Ishida M; Baba A; Imamura Y
    Acta Ophthalmol; 2018 Aug; 96(5):e662-e663. PubMed ID: 29671951
    [No Abstract]   [Full Text] [Related]  

  • 47. Tailoring individualized treatment plans for acne.
    Harper JC
    Cutis; 2008 Jan; 81(1 Suppl):23-5. PubMed ID: 18338655
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mineralocorticoid Antagonists in the Treatment of Central Serous Chorioretinopathy: A Comparative Analysis.
    Kapoor KG; Wagner AL
    Ophthalmic Res; 2016; 56(1):17-22. PubMed ID: 26982318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nonsteroidal mineralocorticoid antagonists in diabetic kidney disease.
    Dojki FK; Bakris G
    Curr Opin Nephrol Hypertens; 2017 Sep; 26(5):368-374. PubMed ID: 28771453
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Microvascular perfusion and transport in the diabetic heart.
    McDonagh PF; Hokama JY
    Microcirculation; 2000 Jun; 7(3):163-81. PubMed ID: 10901496
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Aldosterone antagonism in heart failure.
    Richards AM; Nicholls MG
    Lancet; 1999 Sep; 354(9181):789-90. PubMed ID: 10485716
    [No Abstract]   [Full Text] [Related]  

  • 52. Long-term effects of spironolactone on proteinuria and kidney function in patients with chronic kidney disease.
    Bianchi S; Bigazzi R; Campese VM
    Kidney Int; 2006 Dec; 70(12):2116-23. PubMed ID: 17035949
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of the glucagon-like peptide-1 analogue liraglutide on coronary microvascular function in patients with type 2 diabetes - a randomized, single-blinded, cross-over pilot study.
    Faber R; Zander M; Pena A; Michelsen MM; Mygind ND; Prescott E
    Cardiovasc Diabetol; 2015 Apr; 14():41. PubMed ID: 25896352
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Eplerenone in patients with acute myocardial infarction complicated by heart failure.
    Ramaraj R
    Hypertension; 2008 Dec; 52(6):e147; author reply e48. PubMed ID: 18936342
    [No Abstract]   [Full Text] [Related]  

  • 55. Recovery from ischemic acute kidney injury by spironolactone administration.
    Sánchez-Pozos K; Barrera-Chimal J; Garzón-Muvdi J; Pérez-Villalva R; Rodríguez-Romo R; Cruz C; Gamba G; Bobadilla NA
    Nephrol Dial Transplant; 2012 Aug; 27(8):3160-9. PubMed ID: 22516623
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Serum asymmetric dimethylarginine as a marker of coronary microcirculation in patients with non-insulin dependent diabetes mellitus: correlation with coronary flow reserve.
    Kawata T; Daimon M; Hasegawa R; Teramoto K; Toyoda T; Sekine T; Yamamoto K; Uchida D; Himi T; Yoshida K; Komuro I
    Heart; 2005 Dec; 91(12):1607-8. PubMed ID: 16287749
    [No Abstract]   [Full Text] [Related]  

  • 57. Selective aldosterone blockade with eplerenone reduces albuminuria in patients with type 2 diabetes.
    Epstein M; Williams GH; Weinberger M; Lewin A; Krause S; Mukherjee R; Patni R; Beckerman B
    Clin J Am Soc Nephrol; 2006 Sep; 1(5):940-51. PubMed ID: 17699311
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mineralocorticoid receptors mediate cardiac remodelling in morphine-dependent rats.
    Mesripour A; Iyer A; Brown L
    Basic Clin Pharmacol Toxicol; 2012 Aug; 111(2):75-80. PubMed ID: 22304485
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the role of brain mineralocorticoid (type I) and glucocorticoid (type II) receptors in neuroendocrine regulation.
    Ratka A; Sutanto W; Bloemers M; de Kloet ER
    Neuroendocrinology; 1989 Aug; 50(2):117-23. PubMed ID: 2550833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.